Emerging Fungal Pathogens: Evolving Challenges to Immunocompromised Patients-Reference-Cited by-同舟云学术

Emerging Fungal Pathogens: Evolving Challenges to Immunocompromised Patients

Published:2014-04-09 Issue: Volume: Page:221-232
ISSN:
Container-title:Emerging Infections 1
language:
Short-container-title:

Author:

Walsh Thomas J.¹

Affiliation:

1. Immunocompromised Host Section, Division of Clinical Sciences; National Cancer Institute, National Institutes of Health; Building 10, Room 13N240 Bethesda MD 20892

Publisher

ASM Press

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1128/9781555816940.ch15/fullpdf

Reference51 articles.

1. Dose-dependent antifungal activity and nephrotoxicity of amphotericin B colloidal dispersion in experimental pulmonary aspergillosis;Allende;Antimicrob. Agents Chemother.,1994

2. New spectrum of fungal infections in patients with cancer;Anaissie;Rev. Infect. Dis.,1989

3. Azole therapy for trichosporonosis: clinical evaluation of eight patients. experimental therapy for murine infection, and review;Anaissie;Clin. Infect. Dis.,1992

4. The emerging role of Fusarium infections in patients with cancer;Anaissie;Medicine,1988

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deep Phaeohyphomycosis;Topley & Wilson's Microbiology and Microbial Infections;2010-03-15

2. Safety, Tolerance, and Pharmacokinetics of High-Dose Liposomal Amphotericin B (AmBisome) in Patients Infected with Aspergillus Species and Other Filamentous Fungi: Maximum Tolerated Dose Study;Antimicrobial Agents and Chemotherapy;2001-12

3. Professional Specialty Cleaning: A Critical Element of Fungal Reservoir Control in Homes of the Immunocompromised and Hypersensitive;Applied Biosafety;2001-06